Trial Profile
Aliskiren Combined With Losartan in Immunoglobulin A Nephropathy: an Open-Label Pilot Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jul 2015
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Losartan (Primary)
- Indications Proteinuria
- Focus Therapeutic Use
- 04 Aug 2011 Actual end date (December 2010) added as reported by ClinicalTrials.gov.
- 04 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2010 Actual initiation date (Jul 2009) added as reported by ClinicalTrials.gov.